A systematic literature review on the diagnostic accuracy of serological tests for Lyme borreliosis
This report provides an overview of the diagnostic accuracy of serological tests for different target conditions of Lyme borreliosis.
External quality assessment scheme for Neisseria meningitidis - 2014
In July 2014, a panel of two viable isolates of N. meningitidis of the major disease-causing serogroups with three simulated cerebrospinal fluid (non-culture) samples for molecular studies, was sent by UK NEQAS to 30 reference laboratories in the IBD-labnet surveillance network for quality assessment testing. This report summarises the diagnostic results submitted by the participating laboratories.
External quality assessment scheme for Streptococcus pneumoniae – 2014
In July 2014, a panel of three strains of Streptococcus pneumoniae and two simulated samples of cerebrospinal fluid was sent to 30 reference laboratories in the IBD-labnet surveillance network for quality assessment testing. This report summarises the diagnostic results submitted by the participating laboratories.
Syphilis - Annual Epidemiological Report 2016 [2014 data]
In 2014, 24 541 syphilis cases were reported in 29 EU/EEA Member States (data were not available from Austria and Liechtenstein), an overall rate of 5.1 per 100 000 population. Reported syphilis rates were six times higher in men than in women.
Communicable disease threats report, 10-16 April 2016, week 15
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 April 2016 and includes updates on Zika virus, Ebola virus disease, and yellow fever in Angola.
- Ebola haemorrhagic fever
- Emerging and Vector-borne Diseases Programme
- Middle East respiratory syndrome coronavirus
- migrant health
- public health threat
- seasonal influenza
- Vaccine Preventable Diseases Programme
- Western Africa
- yellow fever
- Zika virus infection - Outbreak in the Americas
Rapid risk assessment: Carbapenem-resistant Enterobacteriaceae, 14 April 2016
This rapid risk assessment provides several options to reduce the risk of CRE, e.g. treatment options, transmission prevention and measures related to the healthcare system.
Influenza virus characterisation, Summary Europe, March 2016
From week 40/2015, the start of weekly reporting on influenza activity in the WHO European Region, to week 13/2016, over 120 000 influenza detections across the Region have been reported. This surveillance report presents a summary of the influenza virus characterisation in Europe in the course of the 2015–2016 influenza season.
Rapid risk assessment: Zika virus disease epidemic: potential association with microcephaly and Guillain–Barré syndrome - 5th update, 12 April 2016
This update assesses the risks associated with the Zika virus epidemic currently affecting countries in the Americas, taking account of the latest information available.
Communicable disease threats report, 3-9 April 2016, week 14
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 April 2016 and includes updates on Zika virus, haemolytic uraemic syndrome in Romania, and yellow fever in Angola.
Zika virus disease epidemic: Preparedness planning guide for diseases transmitted by Aedes aegypti and Aedes albopictus
The aim of this document is to highlight measures that can effectively reduce the risk of importation and local transmission of pathogens transmitted by Ae. aegypti and Ae. albopictus. The main diseases of concern in this context are Zika, dengue, chikungunya and yellow fever.